91 related articles for article (PubMed ID: 16184927)
1. [Clinical significant of semiquantificating DNA topoisomerase- I mRNA in colorectal cancer].
Ishida H; Shirakawa K; Ohsawa T; Hayashi Y; Okada N; Nakada H; Yokoyama M
Gan To Kagaku Ryoho; 2005 Sep; 32(9):1295-9. PubMed ID: 16184927
[TBL] [Abstract][Full Text] [Related]
2. Topoisomerase-I, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patients.
Paradiso A; Xu J; Mangia A; Chiriatti A; Simone G; Zito A; Montemurro S; Giuliani F; Maiello E; Colucci G
Int J Cancer; 2004 Aug; 111(2):252-8. PubMed ID: 15197779
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of thymidylate synthase, topoisomerase-1 and Ki-67 in advanced colorectal cancer patients on irinotecan and fluorouracil treatment].
Xu JM; Zhu BD; Mangia A; Simone G; Montemurro S; Giuliani F; Maiello E; Colucci G; Paradiso A
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):312-5. PubMed ID: 15996331
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy.
Kostopoulos I; Karavasilis V; Karina M; Bobos M; Xiros N; Pentheroudakis G; Kafiri G; Papakostas P; Vrettou E; Fountzilas G
BMC Cancer; 2009 Sep; 9():339. PubMed ID: 19775480
[TBL] [Abstract][Full Text] [Related]
5. CES2, ABCG2, TS and Topo-I primary and synchronous metastasis expression and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI regimen.
Silvestris N; Simone G; Partipilo G; Scarpi E; Lorusso V; Brunetti AE; Maiello E; Paradiso A; Mangia A
Int J Mol Sci; 2014 Sep; 15(9):15767-77. PubMed ID: 25198900
[TBL] [Abstract][Full Text] [Related]
6. A quantitative RT-PCR method to determine topoisomerase I mRNA levels in human tissue samples.
Durand-Faucher K; Rabinovitch-Chable H; Dzugan H; Charret S; Aubry K; Genet D; Léobon S; Tubiana-Mathieu N; Cook-Moreau J; Rigaud M; Sturtz FG
Clin Chem Lab Med; 2005; 43(7):707-14. PubMed ID: 16207129
[TBL] [Abstract][Full Text] [Related]
7. Role of topoisomerase I and thymidylate synthase expression in sporadic colorectal cancer: associations with clinicopathological and molecular features.
Azzoni C; Bottarelli L; Cecchini S; Ziccarelli A; Campanini N; Bordi C; Sarli L; Silini EM
Pathol Res Pract; 2014 Feb; 210(2):111-7. PubMed ID: 24332575
[TBL] [Abstract][Full Text] [Related]
8. Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib ("Iressa") and the DNA topoisomerase I inhibitor CPT-11 (irinotecan) in human colorectal cancer cells.
Koizumi F; Kanzawa F; Ueda Y; Koh Y; Tsukiyama S; Taguchi F; Tamura T; Saijo N; Nishio K
Int J Cancer; 2004 Jan; 108(3):464-72. PubMed ID: 14648715
[TBL] [Abstract][Full Text] [Related]
9. No alteration in DNA topoisomerase I gene related to CPT-11 resistance in human lung cancer.
Ohashi N; Fujiwara Y; Yamaoka N; Katoh O; Satow Y; Yamakido M
Jpn J Cancer Res; 1996 Dec; 87(12):1280-7. PubMed ID: 9045964
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase I expression in tumors as a biological marker for CPT-11 chemosensitivity in patients with colorectal cancer.
Ikeguchi M; Arai Y; Maeta Y; Ashida K; Katano K; Wakatsuki T
Surg Today; 2011 Sep; 41(9):1196-9. PubMed ID: 21874414
[TBL] [Abstract][Full Text] [Related]
11. Molecular determinants of irinotecan efficacy.
Vallböhmer D; Iqbal S; Yang DY; Rhodes KE; Zhang W; Gordon M; Fazzone W; Schultheis AM; Sherrod AE; Danenberg KD; Lenz HJ
Int J Cancer; 2006 Nov; 119(10):2435-42. PubMed ID: 16894565
[TBL] [Abstract][Full Text] [Related]
12. CPT-11 may provide therapeutic efficacy for esophageal squamous cell cancer and the effects correlate with the level of DNA topoisomerase I protein.
Nakajima Y; Miyake S; Nagai K; Kawano T; Iwai T
Jpn J Cancer Res; 2001 Dec; 92(12):1335-41. PubMed ID: 11749700
[TBL] [Abstract][Full Text] [Related]
13. Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer.
Okumura K; Mekata E; Shiomi H; Naitoh H; Abe H; Endo Y; Kurumi Y; Tani T
Cancer Chemother Pharmacol; 2008 Apr; 61(4):587-94. PubMed ID: 17520254
[TBL] [Abstract][Full Text] [Related]
14. Topoisomerase I expression correlates to response to neoadjuvant irinotecan-based chemoradiation in rectal cancer.
Horisberger K; Erben P; Muessle B; Woernle C; Stroebel P; Kaehler G; Wenz F; Hochhaus A; Post S; Willeke F; Hofheinz RD;
Anticancer Drugs; 2009 Jul; 20(6):519-24. PubMed ID: 19436196
[TBL] [Abstract][Full Text] [Related]
15. [Expression of mRNA levels of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase of colorectal cancer--relationships among mRNA levels in association with response to 5-FU based treatment].
Ishida H; Shirakawa K; Ohsawa T; Sobajima J; Hayashi Y; Nakada H; Yokoyama M; Hashimoto D
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1929-34. PubMed ID: 16282729
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer.
Mauritz R; Giovannetti E; Beumer IJ; Smid K; Van Groeningen CJ; Pinedo HM; Peters GJ
Clin Colorectal Cancer; 2009 Jul; 8(3):146-54. PubMed ID: 19632929
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma.
Ren DN; Kim IY; Koh SB; Chang SJ; Eom M; Yi SY; Seong SH; Kim MD; Bronner MP; Cho MY
J Surg Oncol; 2009 Dec; 100(7):546-52. PubMed ID: 19722231
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase I protein expression in primary colorectal cancer and recurrences after 5-FU-based adjuvant chemotherapy.
Gouveris P; Lazaris AC; Papathomas TG; Nonni A; Kyriakou V; Delladetsima J; Patsouris ES; Tsavaris N
J Cancer Res Clin Oncol; 2007 Dec; 133(12):1011-5. PubMed ID: 17605046
[TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression after administration of 5-fluorouracil to patients with colorectal cancer.
Mauritz R; van Groeningen CJ; Smid K; Jansen G; Pinedo HM; Peters GJ
Int J Cancer; 2007 Jun; 120(12):2609-12. PubMed ID: 17330233
[TBL] [Abstract][Full Text] [Related]
20. Gene expression of vascular endothelial growth factor A, thymidylate synthase, and tissue inhibitor of metalloproteinase 3 in prediction of response to bevacizumab treatment in colorectal cancer patients.
Watanabe T; Kobunai T; Yamamoto Y; Matsuda K; Ishihara S; Nozawa K; Iinuma H; Ikeuchi H
Dis Colon Rectum; 2011 Aug; 54(8):1026-35. PubMed ID: 21730794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]